76. Deputy Bríd Smith asked the Minister for Health the reason spending on prescribed drugs according to a recent survey here remains extremely high, second only to Germany in the EU, while lifesaving drugs, such as Orkambi for cystic fibrosis, are refused funding due to price gouging by pharmaceutical companies; and if he will make a statement on the matter. [37960/16]

Summary

76. Deputy Bríd Smith asked the Minister for Health the reason spending on prescribed drugs according to a recent survey here remains extremely high, second only to Germany in the EU, while lifesaving drugs, such as Orkambi for cystic fibrosis, are refused funding due to price gouging by pharmaceutical companies; and if he will make a statement on the matter. [37960/16]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 1 December 2016

   Medicinal Products Expenditure

   76. Deputy Bríd Smith asked the Minister for Health the reason spending on prescribed drugs according to a recent survey here remains extremely high, second only to Germany in the EU, while lifesaving drugs, such as Orkambi for cystic fibrosis, are refused funding due to price gouging by pharmaceutical companies; and if he will make a statement on the matter. [37960/16]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Expenditure

  xml · EN · 1 December 2016

  ViewDownloadOpen at official source

Sponsors

• Bríd Smith · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.